Original language | English |
---|---|
Pages (from-to) | 425-425 |
Journal | European Journal of Cancer. Supplement |
Volume | 3 |
Issue number | 2 |
Publication status | Published - Oct 2005 |
A phase 1 B, open-label, dose-escalation study of bortezomib (Btz) in combination with gemcitabine (G) and cisplatin (C) in the first-line treatment of patients with advanced solid tumors: preliminary results
J. Voortman, E. F. Smit, B. C. Kuenen, H. van de Velde, G. Giaccone
Research output: Contribution to journal › Meeting Abstract › Academic